Expertise in
4
conditions

Stefani Parmentier

Winnenden, BW, DE 
Expertise in
4
conditions
Winnenden, BW, DE 

Overview

Stefani Parmentier practices practicing medicine in Winnenden, Germany.

Ms. Parmentier is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Acute Erythroid Leukemia (AEL), Acute Myeloid Leukemia (AML), Leukemia, Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Winnenden, BW, Germany
Other Locations
Murr, BW, Germany
Dresden, SN, Germany
Waiblingen, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy
Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug
Study Drugs: Peginterferon ?2b, Nilotinib
Study Phase: Phase 3
A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent
A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Drug
Study Drug: Rigosertib
Study Phase: Phase 3
View 1 Less Clinical Trial

31 Total Publications

Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry.
Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry.
Journal: Annals of hematology
Published: November 10, 2025

Frequently Asked Questions about Stefani Parmentier

Is Stefani Parmentier a top-rated expert for Acute Erythroid Leukemia (AEL)?

MediFind is an objective health platform that identifies experts based on real-world data. Stefani Parmentier is classified as an Distinguished expert for Acute Erythroid Leukemia (AEL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stefani Parmentier participate in research or clinical trials?

Yes. Stefani Parmentier has published 31 articles and abstracts on conditions like Acute Erythroid Leukemia (AEL). You can view a list of Stefani Parmentier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Parmentier's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile